| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Tomas Gustafsson CEO | XSTO Exchange | - ISIN |
| Sweden Country | 3 Employees | - Last Dividend | - Last Split | - IPO Date |
PExA AB (publ) specializes in the development and commercialization of diagnostic tools for a wide spectrum of respiratory diseases, including asthma, tuberculosis, cystic fibrosis, lung cancer, chronic airway inflammation, and chronic obstructive pulmonary diseases (COPDs). Leveraging advanced research instruments, the company has a strong focus on facilitating lung researchers in collecting microscopic particles and biomarkers from the small airways, which are critical in early disease detection and management. Established in 2014, with its headquarters situated in Gothenburg, Sweden, PExA AB stands at the forefront of noninvasive pulmonary diagnostics. The company has established prominent research collaboration agreements with high-caliber entities like Janssen Research & Development, LLC, and the University of Gothenburg, aimed at uncovering new biomarkers in exhaled breath, showcasing its commitment to advancing respiratory disease research and diagnostics.
This cutting-edge instrument is designed for the non-invasive collection of particles in exhaled air, presenting a significant advancement in respiratory diagnostics. The PExA 2.0 system allows for the safe and efficient gathering of biological markers from the lungs, aiding in the early detection and management of various pulmonary diseases. Its non-invasive nature makes it particularly valuable in clinical settings, offering a patient-friendly alternative to traditional diagnostic methods.
To support and enhance the functionality of the PExA 2.0 instrument, PExA AB provides a comprehensive range of accessories. This includes substrate surfaces for collecting exhaled particles, various nozzle designs to accommodate different use cases, and essential parts and service kits to ensure the longevity and optimal performance of the instruments. These accessories are integral to the PExA system, ensuring versatility and ease of integration into different research settings.
Understanding the complexities and challenges of lung research and diagnostics, PExA AB offers extensive support services to its clients. This encompasses technical support, maintenance, and training on the usage of its PExA 2.0 instrument and accessories. By providing these services, the company ensures that lung research centers, academia, and pharmaceutical companies can maximize the utility of PExA technology in their ongoing research and diagnostic endeavors.